SCHEMBL2808784

SCHEMBL2808784

C/C(=C\Oc1cccc(C)c1)C(=O)Nc1cc(C)cc(C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.45
HSD17B10 Q99714 1/20 0.45
THRB P10828 1/20 0.43
MAPK1 P28482 3/20 0.43
FAAH O00519 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP3A4 P08684 1/20 0.43
TP53 P04637 2/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
NPC1 O15118 2/20 0.41
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
HTT P42858 2/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808788 1.00 LMNA (0.45) LMNAHSD17B10THRBMAPK1FAAH
SCHEMBL2810961 0.89 NPC1 (0.46) LMNAHSD17B10MAPK1ALDH1A1TP53
SCHEMBL2811168 0.89 HTT (0.50) LMNAHSD17B10MAPK1FAAHALDH1A1
SCHEMBL2811164 0.89 HTT (0.50) LMNAHSD17B10MAPK1FAAHALDH1A1
SCHEMBL2810955 0.89 NPC1 (0.46) LMNAHSD17B10MAPK1ALDH1A1TP53
SCHEMBL2807529 0.86 MAPK1 (0.54) LMNAHSD17B10MAPK1FAAHALDH1A1
SCHEMBL2807524 0.86 MAPK1 (0.54) LMNAHSD17B10MAPK1FAAHALDH1A1
SCHEMBL2808853 0.86 NPC1 (0.49) MAPK1ALDH1A1TP53MEN1KMT2A
SCHEMBL12851351 0.86 MAPT (0.44) LMNAHSD17B10MAPK1FAAHALDH1A1
SCHEMBL2808858 0.86 NPC1 (0.49) MAPK1ALDH1A1TP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 LMNA 2201/4885HSD17B10 1243/4885THRB 259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.